Nyxoah Taps Former Teleflex CEO Liam Kelly to Lead Next Phase
NYXH is trading near its 52-week low of $1.26 (8.7% above the low).
Summary
Nyxoah appointed Liam Kelly, former Teleflex CEO, as its new Chief Executive Officer effective October 1, 2026, succeeding Olivier Taelman. Kelly's extensive U.S. medtech experience is aimed at accelerating the company's U.S. commercial traction for its Genio sleep apnea device.
Key Events · Executive and Board Changes · NYXH
-
New CEO Appointed
Liam Kelly, former Chairman, President and CEO of Teleflex Incorporated (NYSE: TFX), has been appointed as Nyxoah's CEO effective October 1, 2026, succeeding Olivier Taelman.
-
U.S. Commercial Focus
The appointment reflects Nyxoah's evolution into a U.S.-focused commercial organization following FDA approval and launch of Genio in the United States.
-
Executive Transition Context
This follows the CFO departure announced September 22, 2026, with former CFO Loic Moreau stepping in as interim, indicating a broader leadership transition.
-
Leadership Background
Kelly brings over 25 years of medtech leadership, including scaling Teleflex as CEO from 2018 to January 2026 and prior senior roles at Hill-Rom Holdings.
Analysis · NYXH · Industrial Applications And Services
Nyxoah has appointed Liam Kelly, the former Chairman, President and CEO of Teleflex, as its new CEO effective October 1, 2026. Kelly brings over 25 years of medtech leadership experience, including scaling Teleflex into a global medical technology company. The appointment comes as Nyxoah shifts its focus to U.S. commercialization following FDA approval of its Genio sleep apnea device in August 2025. This leadership change follows the recent CFO departure announced on September 22, 2026, signaling a broader executive transition as the company accelerates its U.S. growth strategy.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.6% of the 1615 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NYXH was trading at $1.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $139.5M. The 52-week trading range was $1.26 to $6.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.